RXRX - Recursion Pharmaceuticals Inc Broker Consensus Forecast

Recursion Pharmaceuticals (RXRX) is building a digital ecosystem for drug discovery, leveraging robotics and B2B collaborations with pharmaceutical behemoths. This price chart on GURU.Markets, where the consensus forecast stands at 7.35, confirms the company's status as a bold biotech innovator. Meanwhile, high computing costs are temporarily limiting operational efficiency until the company transitions to broad licensing of its ML technologies.

RXRX: Recursion Consensus Target 07/04/2022 - 11/11/2026

Analytical breakdowns for Recursion Pharmaceuticals, Inc. (RXRX)

- share price and consensus valuation forecast:

Price Performance Chart recursion.com|RXRX - Consensus Target

- market capitalization statistics:

Market Capitalization Recursion Pharma|RXRX - Total Company Value

- business book valuation details:

Accounting Value of a Share Recursion|RXRX - Company Net Assets|Capitalization to Book Value Ratio recursion.com|RXRX - Company Total Assets

- issuer credit burden and liquidity indicators:

- earnings and valuation multiples information:

RXRX - Net Income|Projected Future Earnings Recursion Pharmaceuticals|RXRX - Price to Earnings Ratio|Future Price to Earnings Multiple Recursion Pharmaceuticals|RXRX - Price/Earnings to Growth Ratio|Total Company Value to Operating Income Before Depreciation Ratio Recursion Pharma|RXRX - Operating profit EBITDA|Net earnings per share for the last four quarters Recursion|RXRX - Earnings per share for the last twelve months|Earnings per share growth in annualized terms for the last twelve months recursion.com|RXRX - Earnings per share growth in current year|Projected earnings per share growth rate for next year Recursion Pharmaceuticals

Fundamental company analysis:Recursion Corp, RXRX

Signature product of Recursion Pharmaceuticals Inc

For long-term risk management, it is critical to align current quotes with market expectations. The specificity of Recursion Pharmaceuticals (RXRX) lies in the absence of mass-market commercial products and a reliance on partner advances. The consensus price target synthesizes weighted average expert valuations, measuring fundamental growth potential relative to the sector. A positive spread confirms the value of the AI platform; however, high sensitivity to macro trends necessitates caution when investing.

Competing companies